Antinuclear antibodies and mortality in the National Health and Nutrition Examination Survey (1999-2004).
Recent studies suggest antinuclear antibodies (ANA) may be related to mortality risk, but evidence is sparse and inconclusive. Thus, we investigated ANA associations with all-cause and cause-specific mortality in U.S. adults.Our sample included 3357 adults (ages ≥20 years) from the 1999-2004 Nationa...
Main Authors: | Gregg E Dinse, Christine G Parks, Clarice R Weinberg, Helen C S Meier, Caroll A Co, Edward K L Chan, Frederick W Miller |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5633179?pdf=render |
Similar Items
-
Antinuclear antibodies: clinical applications.
by: Wanchu A
Published: (2000-04-01) -
The Prevalence of Antinuclear Antibodies in Patients with Sarcoidosis
by: Senol Kobak, et al.
Published: (2014-01-01) -
Can Antinuclear Antibodies (ANA) be Monoclonal?
by: Laura Biederman, et al.
Published: (2021-01-01) -
Antimitochindrial and antinuclear antibodies in primary biliary cholangitis
by: Dana Saipiyeva, et al.
Published: (2019-06-01) -
Antinuclear Antibody-Positive Ticlopidine-Induced Hepatitis
by: Sander Jo Veldhuyzen van Zanten, et al.
Published: (1996-01-01)